Literature DB >> 3257512

Murine monoclonal isotype switch variants. Detection with rat monoclonal antibodies in ELISA and isolation by sequential sublining.

J H Boot1, M E Geerts, E R De Groot, L A Aarden.   

Abstract

Isotype switch variants, which arise in monoclonal antibody-producing cell lines, can be detected and selected on the basis of sensitive isotype-specific assays. In this study we used a series of enzyme-linked immunosorbent assays specific for murine IgG1, IgG2b, IgG2a, IgE or IgA, which permitted the detection of low frequency switch variants of hybridoma cell lines, irrespective of the specificity of the secreted antibody. In these assays two rat monoclonal antibodies were combined: one specific for the particular heavy-chain isotype, the other for the light-chain isotype, which was identical in all variants. The value of rat monoclonal antibodies for the detection of isotype switch variants is illustrated by the isolation of a series of variant antibodies specific for the CD3 complex present on human T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3257512     DOI: 10.1016/0022-1759(88)90197-4

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  10 in total

1.  Multiple functions of immunoglobulin A in mucosal defense against viruses: an in vitro measles virus model.

Authors:  Huimin Yan; Michael E Lamm; Ewa Björling; Yung T Huang
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  Fc gamma RIII and Fc gamma RIV are indispensable for acute glomerular inflammation induced by switch variant monoclonal antibodies.

Authors:  Angela Giorgini; Heather J Brown; Helen R Lock; Falk Nimmerjahn; Jeffrey V Ravetch; J Sjef Verbeek; Steven H Sacks; Michael G Robson
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

3.  Production of mouse monoclonal antibodies using a continuous cell culture fermenter and protein G affinity chromatography.

Authors:  A Zamboni; I Giuntini; D Gianesello; F Maddalena; F Rognoni; D Herbst
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

4.  Effects of anti-CD3 monoclonal antibodies on functional activity of lymphocytes: studies in vivo and in vitro.

Authors:  K J Parlevliet; M E Chamuleau; S L Yong; M H Raasveld; I J ten Berge; P T Schellekens
Journal:  Clin Exp Immunol       Date:  1995-02       Impact factor: 4.330

5.  Immunoglobulin A antibodies against internal HIV-1 proteins neutralize HIV-1 replication inside epithelial cells.

Authors:  Alison Wright; Huimin Yan; Michael E Lamm; Yung T Huang
Journal:  Virology       Date:  2006-09-07       Impact factor: 3.616

6.  Murine monoclonal antibodies to DNA. A comparison of MRL/lpr NZB/W and chronically graft-versus-host-diseased mice.

Authors:  K Brinkman; A van Dam; H van den Brink; R M Termaat; J Berden; R Smeenk
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

7.  Excretion of human immunodeficiency virus type 1 through polarized epithelium by immunoglobulin A.

Authors:  Alison Wright; Michael E Lamm; Yung T Huang
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

8.  In vivo effects of IgA and IgG2a anti-CD3 isotype switch variants.

Authors:  K J Parlevliet; I J ten Berge; S L Yong; J Surachno; J M Wilmink; P T Schellekens
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

9.  Transmission blockade of Plasmodium falciparum malaria by anti-Pfs230-specific antibodies is isotype dependent.

Authors:  W Roeffen; F Geeraedts; W Eling; P Beckers; B Wizel; N Kumar; T Lensen; R Sauerwein
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

10.  IgG1 protects against renal disease in a mouse model of cryoglobulinaemia.

Authors:  Richard T Strait; Monica T Posgai; Ashley Mahler; Nathaniel Barasa; Chaim O Jacob; Jörg Köhl; Marc Ehlers; Keith Stringer; Shiva Kumar Shanmukhappa; David Witte; Md Monir Hossain; Marat Khodoun; Andrew B Herr; Fred D Finkelman
Journal:  Nature       Date:  2014-11-02       Impact factor: 49.962

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.